Literature DB >> 1848635

Comparison of [3H]ryanodine receptors and Ca++ release from rat cardiac and rabbit skeletal muscle sarcoplasmic reticulum.

I Zimányi1, I N Pessah.   

Abstract

Sarcoplasmic reticulum (SR) vesicles prepared from rat ventricle muscle are isolated, and their [3H]ryanodine-binding and calcium transport properties are studied in detail under active loading conditions in the presence of pyrophosphate. Experiments are performed in tandem with rabbit skeletal SR under identical conditions to allow direct comparisons of the mechanisms by which activators and inhibitors influence the calcium release channel. Ca(++)-induced Ca++ release is demonstrated with both preparations and the cardiac channel is about 1.5-fold more sensitive to activation by Ca++, which is in excellent quantitative agreement with the ability of Ca++ to activate [3H]ryanodine-binding sites. The cardiac and skeletal receptors show major quantitative differences with respect to sensitivity to pharmacologic modulators, cations and pH. The inhibitors ruthenium red, Mg++ and neomycin are significantly more potent in inhibiting the skeletal receptor, whereas the activators daunorubicin and caffeine are significantly more potent towards the cardiac receptor. The ATP analog, beta,gamma-methyleneadenosine 5'-triphosphate, enhances the binding of [3H]ryanodine to the high-affinity site in skeletal SR by a factor of 4 but has a negligible effect on the cardiac receptor, although at suboptimal Ca++ for the binding of ryanodine, beta,gamma-methyleneadenosine 5'-triphosphate activates the cardiac receptor to a greater extent. High levels of salt (1 M NaCl) enhance the rate of [3H]ryanodine association with its binding sites in both preparations, although they selectively reduce the binding-site capacity in skeletal SR due to a failure to maintain a stable equilibrium. Although high- and low-affinity binding of [3H]ryanodine have a similar response to changing pH, the skeletal receptors are significantly more sensitive to pH.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848635

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  23 in total

1.  Ca2+ sparks and Ca2+ waves in saponin-permeabilized rat ventricular myocytes.

Authors:  V Lukyanenko; S Gyorke
Journal:  J Physiol       Date:  1999-12-15       Impact factor: 5.182

2.  Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel (ryanodine receptor isoform 1).

Authors:  G G Du; H Oyamada; V K Khanna; D H MacLennan
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

3.  Green tea catechins are potent sensitizers of ryanodine receptor type 1 (RyR1).

Authors:  Wei Feng; Gennady Cherednichenko; Chris W Ward; Isela T Padilla; Elaine Cabrales; José R Lopez; José M Eltit; Paul D Allen; Isaac N Pessah
Journal:  Biochem Pharmacol       Date:  2010-05-22       Impact factor: 5.858

Review 4.  The Mitochondrial Ca2+ Uniporter: Structure, Function, and Pharmacology.

Authors:  Jyotsna Mishra; Bong Sook Jhun; Stephen Hurst; Jin O-Uchi; György Csordás; Shey-Shing Sheu
Journal:  Handb Exp Pharmacol       Date:  2017

5.  Purification and characterization of ryanotoxin, a peptide with actions similar to those of ryanodine.

Authors:  J Morrissette; M Beurg; M Sukhareva; R Coronado
Journal:  Biophys J       Date:  1996-08       Impact factor: 4.033

6.  Regulation of the cardiac ryanodine receptor channel by luminal Ca2+ involves luminal Ca2+ sensing sites.

Authors:  I Györke; S Györke
Journal:  Biophys J       Date:  1998-12       Impact factor: 4.033

7.  Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).

Authors:  Tram Anh Ta; Isaac N Pessah
Journal:  Neurotoxicology       Date:  2006-08-30       Impact factor: 4.294

8.  Time-related increases in cardiac concentrations of doxorubicinol could interact with doxorubicin to depress myocardial contractile function.

Authors:  P S Mushlin; B J Cusack; R J Boucek; T Andrejuk; X Li; R D Olson
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

9.  Enantiomeric specificity of (-)-2,2',3,3',6,6'-hexachlorobiphenyl toward ryanodine receptor types 1 and 2.

Authors:  Isaac N Pessah; Hans-Joachim Lehmler; Larry W Robertson; Claudio F Perez; Elaine Cabrales; Diptiman D Bose; Wei Feng
Journal:  Chem Res Toxicol       Date:  2009-01       Impact factor: 3.739

10.  Allosterically coupled calcium and magnesium binding sites are unmasked by ryanodine receptor chimeras.

Authors:  Andrew A Voss; Paul D Allen; Isaac N Pessah; Claudio F Perez
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.